We are encouraged by this CHMP positive opinion for lenacapavir, as it is an important step toward a potential new treatment option for individuals with multi-drug resistant HIV,” said Jared ...

A final decision on the marketing authorization of Oczyesa based on the CHMP recommendation is anticipated from the European Commission in mid-2025. For more informationFredrik Tiberg, President & CEO ...

Boehringer Ingelheim has moved a step closer to getting approval for its blockbuster respiratory drug Ofev as the first treatment in the EU for a rare, life-threatening fibrotic disease. The EMA ...

KalVista (KALV) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted an opinion recommending marketing authorization for sebetralstat, a ...

CHMP adopts positive opinion for the marketing authorisation of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer ...

Geron (GERN) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the approval of Rytelo for the treatment ...

CHMP Maintains Negative Opinion on Translarna™ Reexamination Published Oct 18, 2024 6:30am EDT ...

BeOne Medicines' Tevimbra Gets CHMP Positive Opinion Published: July 28, 2025 at 6:45 a.m. ET Share Resize ...